Premium Information is available for this item - Upgrade for $1 a day
6505-00-092-3006
Usp Medrysone Ophthalmic Suspension
6505000923006 000923006 LIQUIFILM NDC00023-0074-05
November 2023
5
Marketplace 6505-00-092-3006
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-092-3006 5+ Documents (More...)
6505-00-227-9829 6505-00-092-3006 6505-01-147-9551 Replacement NATO Stock Numbers Related to 6505
-00-181-8096 6505-00-227-9829 6505-00-092-3006 6505-01-147-9551 https//www.nsnlookup.com /fsg-65/fsc-
Documents 6505-00-181-8096 1+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-092-3006
Usp Medrysone Ophthalmic Suspension Stock Numbers Related to 6505-00-092-3006 6505-00-227-9829
Usp Medrysone Ophthalmic Suspension Stock Numbers Related to 6505-00-092-3006 6505-00-227-9829
Numbers Related to 6505-00-181-8096 6505-00-227-9829 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-092-3006
4NDC11980-0074-05RNCC: 3 | RNVC: 2 | DAC: 4 12 Nov 1971 6505-00-174-2290 Artificial Tears Solution LIQUIFILM
/fsg-53/fsc-5305/de
Restrictions 6505-00-092-3006
6505-00-092-3006 is a Usp Medrysone Ophthalmic Suspension that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-00-092-3006
- NASA (G65V)
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-092-3006
- Part Number
- Manufacturer
- Status
- LIQUIFILM
- Manufacturer
- 24172 - Allergan Inc (Active)
- Incomplete Reference
- Incomplete Reference
- NDC00023-0074-05
- 24172 - Allergan Inc (Active)
- Primary Buy
- Primary Buy
Datasheet 6505-00-092-3006
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 1.000 Percentage, W/V Livetin Active Ingredient
- Pharmaceutical Vehicle Type [AKJQ]
- Aqueous
- Administration [CSGS]
- Ophthalmic
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 5.000 Milliliters
NATO Stock Numbers Related to 6505-00-092-3006
Freight Information 6505-00-092-3006
6505-00-092-3006 has freight characteristics.. 6505-00-092-3006 has a variance between NMFC and UFC when transported by rail and the description should be consulted.